Study guide
10.1 Carbohydrates
NBCE Part I Basic Sciences Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Format, Scoring, and Eligibility 1.3 Domain Weights and Study Strategy
2 General Anatomy: Surface, Bone, and Joints
2.1 Topographical Anatomy 2.2 Osteology of the Appendicular Skeleton 2.3 Arthrology and Syndesmology of the Appendicular Skeleton
3 General Anatomy: Muscle, Heart, and Lymph
3.1 Myology of the Appendicular Skeleton 3.2 Cardiovascular and Lymphatic Systems 3.3 Digestive System
4 General Anatomy: Respiratory, Urogenital, and Endocrine
4.1 Respiratory System 4.2 Urogenital System 4.3 Endocrine System Anatomy
5 Spinal Anatomy: Axial Skeleton
5.1 Osteology of the Axial Skeleton 5.2 Myology of the Axial Skeleton 5.3 Arthrology and Syndesmology of the Axial Skeleton
6 Spinal Anatomy: Neural Structures and Special Senses
6.1 Central Nervous System and Related Structures 6.2 Peripheral and Autonomic Nervous Systems 6.3 Organs of Special Senses
7 Physiology: Nerve, Muscle, and Circulation
7.1 Neurophysiology 7.2 Muscle Physiology 7.3 Cardiovascular Physiology
8 Physiology: Respiration, Kidney, and Gut
8.1 Respiratory Physiology 8.2 Body Fluids and Renal Physiology 8.3 Gastrointestinal Physiology
9 Physiology: Reproduction, Endocrine, and Exercise
9.1 Reproductive Physiology 9.2 Endocrine Physiology 9.3 Exercise and Sports Physiology
10 Chemistry: Macromolecules and Enzymes
10.1 Carbohydrates 10.2 Lipids 10.3 Proteins, Amino Acids, and Peptides 10.4 Enzymes
11 Chemistry: Hormones, Nucleic Acids, Vitamins, and Energetics
11.1 Hormones 11.2 Nucleotides and Nucleic Acids 11.3 Vitamins and Minerals 11.4 Biochemical Energetics
12 Pathology: Cellular, Genetic, and Immune Mechanisms
12.1 Fundamentals of Pathology 12.2 Genetic and Congenital Disorders 12.3 Disorders of the Immune System
13 Pathology: Environment, MSK, Nervous, and Organ Systems
13.1 Environmental and Nutritional Diseases 13.2 Disorders of the Musculoskeletal System 13.3 Disorders of the Nervous System 13.4 Diseases of the Organ Systems
14 Microbiology: Immunology, Bacteria, and Viruses
14.1 Immunology 14.2 Bacteria 14.3 Viruses and Prions
15 Microbiology: Fungi, Parasites, and Disease Control
15.1 Fungi 15.2 Parasites 15.3 Epidemiology and Disease Control
10.1 Carbohydrates
Key Takeaways Explain This Topic AI
Phosphofructokinase-1 is the committed step of glycolysis: AMP and fructose-2,6-bisphosphate activate it; ATP and citrate inhibit it.
Hexokinase has a low Km (~0.1 mM) and is inhibited by glucose-6-phosphate; liver glucokinase has a high Km (~10 mM) and is not product-inhibited by glucose-6-phosphate.
Gluconeogenesis bypasses the three irreversible glycolytic steps with pyruvate carboxylase (biotin), PEPCK, fructose-1,6-bisphosphatase, and glucose-6-phosphatase.
The oxidative pentose phosphate pathway committed enzyme is glucose-6-phosphate dehydrogenase; NADPH keeps glutathione reduced, so G6PD deficiency produces oxidant hemolysis.
SGLT1 cotransports glucose and galactose with sodium at the enterocyte apex; GLUT5 carries fructose; GLUT2 exits across the basolateral membrane.
Last updated: August 2026
Chemistry is Session 2, and carbohydrates open the domain
Chemistry is 13% of NBCE Part I and is tested in Session 2 with Pathology and Microbiology. Inside Chemistry, Carbohydrates are 13% . The official test plan asks for catabolic and anabolic pathways, structure/properties/function, and nutritional concepts (food sources and digestion). Citric acid cycle and the electron-transport chain are Biochemical Energetics in the next chapter; stop this section at pyruvate and the NADPH/ribose branches that actually belong to carbohydrate metabolism.
After the tables are automatic, drill mixed items at /practice/nbce-part1 .
Quick Answer: Glucose is a D-aldohexose stored as glycogen (α-1,4 chains, α-1,6 branches). PFK-1 is the committed glycolytic step (AMP and fructose-2,6-bisphosphate on; ATP and citrate off). Gluconeogenesis uses pyruvate carboxylase, PEPCK, fructose-1,6-bisphosphatase, and glucose-6-phosphatase. PPP NADPH protects red cells. SGLT1/GLUT5/GLUT2 handle absorption.
Structure, stereochemistry, and glycosidic bonds
A monosaccharide is a polyhydroxy aldehyde ( aldose ) or ketone ( ketose ). Glucose is an aldohexose; fructose is a ketohexose. Fischer projection D/L is set by the chiral carbon farthest from the carbonyl: almost all mammalian sugars are D . Epimers differ at one chiral carbon (glucose/galactose at C4; glucose/mannose at C2). Anomers differ at the carbonyl carbon after ring closure: α versus β. In solution, glucose mutarotates through the open chain to an equilibrium mixture (~36% α, ~64% β).
Haworth rings: glucose usually a pyranose (six-membered); fructose in sucrose is a furanose (five-membered). The anomeric carbon is the only carbon bonded to two oxygens. If that OH is free, the sugar is reducing (can open and reduce a cupric reagent). If the anomeric carbons of both partners are locked in a glycosidic bond, the disaccharide is nonreducing .
- Molecule Linkage Reducing? Physiologic note
- Maltose Glc-α-1,4-Glc Yes Starch/glycogen digest product
- Isomaltose Glc-α-1,6-Glc Yes Branch leftover after α-amylase
- Lactose Gal-β-1,4-Glc Yes Milk sugar; lactase (β-galactosidase)
- Sucrose Glc-α-1,2-β-Fru No Table sugar; sucrase-isomaltase
- Trehalose Glc-α-1,1-α-Glc No Fungi/insects; trehalase
- Glycogen α-1,4 chains, α-1,6 branches every ~8–12 residues One reducing end Liver and muscle storage
- Amylose Linear α-1,4 One reducing end Plant starch
- Amylopectin α-1,4 plus α-1,6 every ~24–30 One reducing end Plant starch
- Cellulose β-1,4-Glc One reducing end Humans lack cellulase
- Hyaluronan GlcA-β-1,3-GlcNAc repeats Polymer IVD nucleus and synovial fluid GAG
Glycosaminoglycans (GAGs) are repeating disaccharides, usually a uronic acid plus an amino sugar, often sulfated. Aggrecan in the intervertebral disc nucleus pulposus carries chondroitin sulfate and keratan sulfate. The polyanion holds water; that is carbohydrate function, not a Part II disc-herniation lecture. Glycoproteins (N-linked on Asn, O-linked on Ser/Thr) and glycolipids decorate membranes; blood-group antigens are oligosaccharides on red-cell glycolipids and glycoproteins.
Worked stereochemistry item. Galactose is the C4 epimer of glucose. UDP-galactose 4-epimerase (GALE) interconverts UDP-Glc and UDP-Gal so dietary galactose can enter glucose pathways and so glycoprotein synthesis can proceed when lactose is not on the plate.
Digestion, food sources, and absorption
Dietary carbohydrate in a mixed human diet is mostly starch (amylose and amylopectin), sucrose , lactose , and smaller amounts of fructose, glucose, and poorly digested fiber (cellulose, some pectins). Salivary α-amylase (ptyalin) and pancreatic α-amylase are endoglucosidases that attack internal α-1,4 bonds and spare α-1,6 branches and the terminal reducing end. Products are maltose, maltotriose, and α-limit dextrins.
Brush-border oligosaccharidases finish the job: maltase-glucoamylase , sucrase-isomaltase (sucrose plus α-1,6 branches), lactase , trehalase . Lactase declines after weaning in much of the world; undigested lactose draws water and is fermented to gas — osmotic diarrhea, not an allergy.
Transporter Location Cargo Driving force
SGLT1 (SLC5A1) Enterocyte (and renal) apical Glucose and galactose Na+ electrochemical gradient (secondary active)
- GLUT5 (SLC2A5) Enterocyte apical Fructose Facilitated diffusion
- GLUT2 (SLC2A2) Enterocyte basolateral; liver; β-cell Glucose, galactose, fructose Facilitated; high Km
- GLUT1 RBC, blood-brain barrier, glia Glucose Low Km; constitutive
- GLUT4 Skeletal muscle, adipose Glucose Insulin-recruited to the membrane
- GLUT3 Neurons Glucose Very low Km
Ouabain-sensitive Na+/K+-ATPase on the basolateral membrane keeps intracellular sodium low so SGLT1 can run. Oral rehydration solution works because glucose-stimulated sodium (and water) absorption survives in many diarrheas.
Exam trap: insulin does not gate intestinal GLUT2/SGLT1 the way it gates muscle GLUT4. A fed person absorbs starch whether or not insulin has been injected. Insulin does move GLUT4 to the sarcolemma so muscle and fat can clear post-prandial glucose.
Glycolysis: ten steps, three irreversible, one committed
Glycolysis converts glucose to two pyruvate in the cytosol. Energy investment is 2 ATP (hexokinase/glucokinase and PFK-1). Payoff is 4 ATP (phosphoglycerate kinase and pyruvate kinase) plus 2 NADH (glyceraldehyde-3-phosphate dehydrogenase). Net: 2 ATP + 2 NADH per glucose . Anaerobic tissues (RBC always; exercising muscle) regenerate NAD+ by lactate dehydrogenase , so the net is 2 ATP and 2 lactate, no NADH leftover.
- Enzyme Reaction Regulation you must recite
- Hexokinase (most tissues) Glucose → G6P Low Km; inhibited by G6P
Glucokinase (liver, β-cell) Glucose → G6P High Km; induced by insulin; sequestered by GKRP when F6P is high; fructose-1-phosphate releases it
PFK-1 F6P + ATP → F-1,6-BP + ADP Committed step. Activators: AMP, fructose-2,6-bisphosphate. Inhibitors: ATP, citrate
Pyruvate kinase (liver) PEP → pyruvate + ATP Feed-forward by F-1,6-BP; inhibited by ATP and alanine; glucagon/PKA phosphorylation inactivates liver PK
Phosphofructokinase-1 (PFK-1) is the enzyme to know cold. ATP occupancy of an allosteric site raises the K0.5 for fructose-6-phosphate and flattens the sigmoid. AMP reverses that. Citrate reports that the mitochondria are full and further glycolytic carbon is not needed. Fructose-2,6-bisphosphate is the most potent feed-forward activator in liver and the hormone-coupling device:
The bifunctional enzyme PFK-2/FBPase-2 both makes and breaks F-2,6-BP.
Insulin (fed liver): protein phosphatase dephosphorylates the liver bifunctional enzyme → PFK-2 on → F-2,6-BP rises → PFK-1 on → glycolysis.
Glucagon (fasted liver): cAMP-PKA phosphorylates the bifunctional enzyme → FBPase-2 on → F-2,6-BP falls → PFK-1 off, and the same fall de-inhibits fructose-1,6-bisphosphatase so gluconeogenesis can run.
Muscle PFK-2 is a different isoform and is not turned off by glucagon/PKA the same way — muscle is not in the business of exporting glucose.
Pyruvate fates (do not dump the whole TCA map here): aerobic tissues send pyruvate into mitochondria via pyruvate dehydrogenase (TPP, lipoamide, CoA, FAD, NAD+) to acetyl-CoA. PDH is inactivated by phosphorylation (PDH kinase, stimulated by acetyl-CoA, NADH, ATP) and reactivated by PDH phosphatase (stimulated by insulin and Ca2+). Cytosolic pyruvate can also transaminate to alanine (Cahill cycle) or be reduced to lactate (Cori cycle).
2,3-bisphosphoglycerate (2,3-BPG) in red cells is a glycolytic shunt (Rapoport-Luebering) that lowers hemoglobin O2 affinity. That is why a glycolysis-block in RBCs can present as both hemolysis and a change in the oxygen curve — chemistry meeting respiratory physiology.
Chemistry domain topic weights (percent of Chemistry; Chemistry itself is 13% of Part I)
Loading diagram... PFK-1 sits at the glycolysis–gluconeogenesis switch with fructose-2,6-bisphosphate
Gluconeogenesis: four bypasses, not a simple reverse
Liver (and to a lesser extent kidney cortex) can make free glucose. Muscle cannot , because it lacks glucose-6-phosphatase . Reversing glycolysis is thermodynamically illegal at the three kinase steps, so gluconeogenesis uses four enzymes:
Pyruvate carboxylase (mitochondrial, biotin , acetyl-CoA is an obligate allosteric activator) carboxylates pyruvate to oxaloacetate. No acetyl-CoA, no gluconeogenesis — a starved liver that cannot β-oxidize (carnitine defect, CPT-I defect) becomes hypoglycemic.
PEPCK decarboxylates and phosphorylates oxaloacetate to PEP (GTP). Cytosolic PEPCK is glucagon/cortisol-induced and insulin-repressed.
Fructose-1,6-bisphosphatase hydrolyzes F-1,6-BP. Inhibited by AMP and by F-2,6-BP — the mirror of PFK-1.
Glucose-6-phosphatase (endoplasmic reticulum of liver and kidney; glucose-6-phosphate translocase plus catalytic subunit) releases free glucose into blood.
Carbon sources: lactate (Cori), glucogenic amino acids (especially alanine), glycerol from lipolysis (enters at DHAP via glycerol kinase — liver has it, adipose does not), and propionyl-CoA from odd-chain fatty acids. Acetyl-CoA from even-chain fat cannot make net glucose in humans: the two carbons that enter citrate leave as CO2 in the isocitrate dehydrogenase and α-ketoglutarate dehydrogenase reactions.
Energy cost: 6 ATP equivalents per glucose from 2 pyruvate (pyruvate carboxylase 2 ATP, PEPCK 2 GTP, 3-phosphoglycerate kinase 2 ATP). That is why gluconeogenesis is a fasting, glucagon/cortisol, fatty-acid-oxidation-supported pathway.
Glycogen: synthesis, phosphorolysis, and the classic storage diseases
Glycogenesis. Glucose-6-phosphate → glucose-1-phosphate (phosphoglucomutase) → UDP-glucose (UDP-glucose pyrophosphorylase; pyrophosphate hydrolysis pulls). Glycogen synthase adds UDP-glucose to a nonreducing end with α-1,4 bonds; it needs a glycogenin primer. Branching enzyme (amylo-α-(1,4)→α-(1,6)-transglycosylase) moves a ~6–8 residue oligosaccharide to a C6-OH, creating a branch. Branches raise solubility and the number of nonreducing ends.
Glycogenolysis. Glycogen phosphorylase (pyridoxal phosphate) phosphorolyzes α-1,4 bonds to glucose-1-phosphate until four residues from a branch. Debranching enzyme has two activities: 4:4 transferase (moves the outer three glucoses) and 1,6-glucosidase (releases the branch-point glucose as free glucose , not G1P). Liver G6Pase then exports glucose. Muscle phosphorylase feeds glycolysis locally.
Hormone cascade you will see again in the enzyme section: glucagon (liver) or epinephrine (liver and muscle) → cAMP → PKA → phosphorylase kinase → phosphorylase a (active). The same PKA phosphorylates glycogen synthase to the inactive form. Insulin activates protein phosphatase-1 , reversing both. Muscle phosphorylase is also opened by AMP and by Ca2+-calmodulin on phosphorylase kinase during contraction — so a contracting muscle dumps glycogen without waiting for a hormone.
Disease Enzyme Organ High-yield picture
von Gierke (I) Glucose-6-phosphatase Liver, kidney Severe fasting hypoglycemia, lactic acidosis, hepatomegaly, hyperuricemia
Pompe (II) Lysosomal acid α-glucosidase Muscle, heart Infantile hypotonia and cardiomyopathy; glycogen in lysosomes
- Cori (III) Debranching enzyme Liver ± muscle Hypoglycemia milder than I; short outer branches
- Andersen (IV) Branching enzyme Liver Long unbranched chains; cirrhosis
McArdle (V) Muscle glycogen phosphorylase Skeletal muscle Exercise cramps, myoglobinuria; second-wind ; no rise in lactate on ischemic forearm test
- Hers (VI) Liver glycogen phosphorylase Liver Mild hypoglycemia, hepatomegaly
- Pentose phosphate pathway, fructose, and galactose
Oxidative PPP (cytosol): glucose-6-phosphate dehydrogenase (G6PD, NADP+) → 6-phosphogluconolactone → 6-phosphogluconate dehydrogenase → ribulose-5-phosphate + CO2. Net per glucose-6-phosphate through both dehydrogenases: 2 NADPH + 1 CO2 . NADPH is the reductant for fatty-acid and cholesterol synthesis and for glutathione reductase . RBCs have no other NADPH source; G6PD deficiency (X-linked) presents as hemolysis after primaquine, sulfa drugs, dapsone, infection, or fava beans. Heinz bodies and bite cells are the smear vocabulary.
Nonoxidative PPP: transketolase ( thiamine pyrophosphate ) and transaldolase shuffle 3–7 carbon sugars so the cell can make ribose-5-phosphate for nucleotides without NADPH, or make extra NADPH without ribose (recycle to F6P and GAP and re-enter glycolysis/gluconeogenesis). A transketolase assay with and without TPP is an old functional test of thiamine status.
Fructose. Hepatic fructokinase phosphorylates fructose to fructose-1-phosphate . Aldolase B splits F1P to DHAP and glyceraldehyde. That bypasses PFK-1, so a large fructose load can dump triose phosphates into liver and raise lipogenesis. Essential fructosuria (fructokinase) is benign — fructose spills in urine. Hereditary fructose intolerance (aldolase B) traps F1P, sequesters phosphate, stops glycogenolysis and gluconeogenesis, and causes hypoglycemia, liver injury, and aversion to sweets after weaning.
Galactose. Galactokinase → Gal-1-P. GALT (galactose-1-phosphate uridyltransferase) trades with UDP-glucose to make UDP-galactose + G1P. GALE epimerizes UDP-Gal/UDP-Glc. Classic galactosemia (GALT) : feeding a neonate milk produces liver failure, E. coli sepsis risk, cataracts (galactitol via aldose reductase), and Fanconi-type renal wasting. Galactokinase deficiency is mainly cataracts. Remove lactose; soy formulas are the practical move.
Ethanol is not a carbohydrate, but it wrecks carbohydrate numbers: alcohol dehydrogenase and aldehyde dehydrogenase generate NADH. High NADH drives oxaloacetate toward malate (starving gluconeogenesis), pyruvate toward lactate, and DHAP toward glycerol-3-phosphate (fatty liver). Fasting plus binge drinking → hypoglycemia and lactic acidosis. That item is carbohydrate regulation, not a bar-exam fact.
Lock PFK-1, the four bypasses, G6PD, GALT, and aldolase B. Then mix them with lipid and enzyme items at /practice/nbce-part1 .